Reimagining Cancer Care: Why We Can Not Accept the Status Quo
Working at Daiichi Sankyo, cancer was part of my everyday life. But this was different. This was my dad, and it was a diagnosis I knew would not end with the ringing of a bell…
Let Me Tell You About My Aunt Maryann
Translating facts into memorable stories is a powerful craft. Discover how Daiichi Sankyo communications leader Kim Wix inspires action via storytelling.
Translating the Science of ADCs for Patients with Cancer
Informed patients are empowered patients. Which is why helping people with cancer understand their disease, as well as how available treatment options might work for them, is a critical focus of our patient advocacy efforts.
Crafting Meaningful Connections to Benefit Patients
Business development is the craft of making connections. Whether with other companies or within our organization, we need to build those bonds that allow us to be successful.
Beyond Positive & Negative: The Spectrum of HER2 Expression in Cancer
Cancer research and development is a dynamic and ever-evolving field. One significant area of focus is the role of HER2.
Daiichi Sankyo’s HER2 Directed ADC Receives Industry’s Top Award
The Galien Foundation has recognized Daiichi Sankyo’s HER2 directed antibody drug conjugate (ADC) with the prestigious 2024 Prix Galien USA Award for Best Biotechnology Product.
Translating Science for Patients—The Craft of a Passionate Advocate
For cancer patients, the science concerning their disease is sometimes outside of reach. As a patient-centric organization, we are on a mission to break down those barriers.